Mr. George

Chairman

Equibles does not estimate personal net worth.

Get an email with a short summary when LENZ Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.

Get LENZ alerts

About Mr. George

Mr. George is recorded as Chairman at LENZ Therapeutics, Inc. (LENZ) since March 21, 2024. LENZ Therapeutics, Inc. reported in an 8-K filed March 22, 2024 that Mr. George was appointed Chair of the Board, effective March 21, 2024. LENZ Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at LENZ Therapeutics, Inc. includes Daniel Chevallard (CEO and CFO), Kimberlee C. Drapkin (CEO, CFO, Chief Accounting Officer and Board Member), Jeff George (Chairman and Board Member) and 6 others.

“Also on March 21, 2024, Mr. George was appointed as the Chair of the Board.”

LENZ Therapeutics, Inc. Form 8-K, filed March 22, 2024 · Read the filing

Affiliation history

LENZ Therapeutics, Inc. (LENZ)
Chairman

SEC 8-K

Current
2024-03-21–present

Company network

LENZ Therapeutics, Inc.

LENZ

Current role

Biotechnology · Healthcare

Chairman

2024-03-21–present

Leadership on record at LENZ Therapeutics, Inc.

Daniel Chevallard CEO, CFO
Kimberlee C. Drapkin CEO, CFO, Chief Accounting Officer, Board Member
Jeff George Chairman, Board Member
Katherine V. Stultz COO
Continuing Directors Board Member
Frederic Guerard Board Member
James McCollum Board Member
Shelley Thunen Board Member
Zach Scheiner Board Member

Recent activity

Executive change Appointed: Chair of the Board LENZ Therapeutics, Inc. (LENZ)
2024-03-21